The fifty-year journey to unlock the potential of mRNA vaccines

Science · Published 8 October 2026 Swipe more like this →

In short: While COVID-19 vaccines appeared almost overnight, they were actually the result of decades of scientific struggle. For years, researchers faced a fundamental hurdle: how to get fragile genetic instructions into human cells without them breaking down before they could work.

The core challenge of mRNA technology lies in delivery. Messenger RNA is inherently unstable, making it difficult to ensure it reaches its destination intact. For a long time, scientists struggled to prevent the genetic material from degrading before it could instruct cells to produce specific proteins. This instability meant that the genetic material often degraded before it could effectively instruct cells. Researchers had to find ways to protect these delicate molecules from being destroyed prematurely.

A major breakthrough occurred in late 1987, when Robert Malone conducted a landmark experiment. He mixed messenger RNA strands with droplets of fat to create what has been described as a 'molecular stew.' This allowed human cells to absorb the mRNA and begin producing proteins from it, proving the concept was possible. This experiment demonstrated that genetic gumbo could successfully trigger protein production within human cells. It served as a foundational moment for the entire field of messenger RNA research.

However, widespread clinical use required more than just successful experiments; it required advances in nanotechnology. It was only through recent progress in nanotechnology that scientists developed lipid nanoparticles. These novel delivery systems act as protective carriers, enhancing the stability and delivery of the mRNA. These lipid nanoparticles serve as essential vehicles for the genetic payload. Such advancements in material science were crucial for making the technology viable for human use.

Today, mRNA platforms are viewed as highly potent, low-cost, and safe alternatives to conventional vaccines. While the COVID-19 pandemic brought these technologies to the forefront, they represent the culmination of work by hundreds of scientists spanning over fifty years of research. Newer iterations, such as self-amplifying mRNA, are currently being studied for even better outcomes. This ongoing evolution suggests that the potential for this platform extends far beyond current applications.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• Beyond COVID: How mRNA Vaccines Are Revolutionizing Medicine and Protecting Endangered Species
• The biological blueprint: how mRNA vaccines turn your cells into tiny factories
• How a chance meeting at a photocopier changed the future of modern medicine
• The architect of mRNA technology became a face of its controversy
• How a demoted researcher’s persistence built the foundation for modern mRNA vaccine technology.
• Could the origins of life be hidden inside ancient space rocks?
• Why winter roads turn into irresistible salt licks for moose
• Why a bird's-eye view is essential for saving frog biodiversity
• The architectural genius behind one of music's most influential voices
• Why do most New Year's resolutions fail and how can you actually succeed?
• The invisible threat of bioaerosols and the tools used to track them
• Why the modern world is losing its connection to the true night sky

More in Science · Latest · A–Z · All topics